# ePRIME: Patient-Reported AEs in Early Phase Trials

> **NCT03461939** · — · COMPLETED · sponsor: **University of Leeds** · enrollment: 30 (actual)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** ePRIME symptom monitoring tool

## Key facts

- **NCT ID:** NCT03461939
- **Lead sponsor:** University of Leeds
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-09
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-08-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-09-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03461939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03461939, "ePRIME: Patient-Reported AEs in Early Phase Trials". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT03461939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*